The preliminary version of the DRG manual for 2022 published in France

28

Feb 2022

On February 15, 2022, the preliminary version of the DRG manual for 2022 was published in France. Introduced changes (new DRGs, change of DRG logic) concern surgical procedures on the breast, interventions for malignant skin tumors, interventions of excision and grafting on the skin and subcutaneous tissue, spondyloplasties.

Introduced changes are described in Volume 1 of the DRG manual.

Considering the heaviness of certain procedures and improved description of concomitant procedures, such as the positioning of markers and the various procedures of simultaneous reconstruction, DRGs for breast reconstructions and other interventions on the breast were changed. Seven new DRGs are introduced instead:

  • 09C16 Total mastectomies with complex reconstructions;
  • 09C17 Isolated complex reconstructions;
  • 09C18 Major interventions for malignant breast tumor with prosthetic reconstruction;
  • 09C19 Major interventions for malignant breast tumor;
  • 09C20 Other interventions for malignant breast tumor;
  • 09C21 Major interventions excluding malignant breast tumor;
  • 09C22 Other interventions excluding malignant breast tumor.

New DRGs are introduced for spondyloplasty and other transcutaneous interventions on the spine:

  • 08K05 Spondyloplasties;
  • 08K06 Other interventional procedures on the spine, stays of less than 2 nights.

The full details about other changes in French can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more